HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-phospholipid-antibodies in patients with relapsing polychondritis.

Abstract
Relapsing polychondritis (RP) is an extremely rare multisystemic disease thought to be of autoimmune origin. In order to assess if RP is associated with anti-phospholipid antibodies (aPL), clinical data and sera of 21 patients with RP were collected in a multicentre study. Concentration of anti-cardiolipin antibodies (aCL) (IgG-, IgM- and IgA-isotypes), anti-phosphatidylserine-antibodies (aPS) (IgG- and IgM-isotypes) and anti-beta-2-glycoprotein I-antibodies (a beta 2 GPI) were measured by ELISA. In eight patients aCL were found to be elevated. One patient had elevated aPS. No patient had elevated a beta 2 GPI. No patient had clinical signs and symptoms of a aPL syndrome. Interestingly, the two RP patients with the highest aPL had concomitant systemic lupus erythematosus (SLE). Therefore the presence of elevated aPL in RP is probably more closely related to an associated SLE than to RP itself. There is no convincing evidence that aPL are associated with RP.
AuthorsM Zeuner, R H Straub, U Schlosser, G Rauh, G Schmitz, J Schölmerich, B Lang
JournalLupus (Lupus) Vol. 7 Issue 1 Pg. 12-4 ( 1998) ISSN: 0961-2033 [Print] England
PMID9493143 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Antiphospholipid
Topics
  • Adolescent
  • Adult
  • Antibodies, Antiphospholipid (blood)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Polychondritis, Relapsing (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: